Publisher
Jaypee Brothers Medical Publishing
Subject
Critical Care and Intensive Care Medicine
Reference7 articles.
1. 1. Chaudhari PB. Nivolumab–pearls of evidence. Indian J Med Paediatr Oncol 2017;38:520–525. DOI: 10.4103/ijmpo.ijmpo_193_16.
2. 2. Touat M, Maisonobe T, Knauss S, Ben Hadj Salem O, Hervier B, Auré K, et al. Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer. Neurology 2018;91(10):985–994. DOI: 10.1212/WNL.0000000000006124.
3. 3. Bourgeois-Vionet J, Joubert B, Bernard E, Angèle Sia M, Pante V, Fabien N, et al. Nivolumab-induced myositis: a case report and a literature review. J Neurol Sci 2018;387:51–53. DOI: 10.1016/j.jns.2018.01.030.
4. 4. Moreira A, Loquai C, Pfohler C, Kähler KC, Knauss S, Heppt MV, et al. Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors. Eur J iCancer 2018;106:12–23. DOI:/i 10.1016/j.ejca.2018.09.033.
5. 5. Avinash MP, Nikhil PG, Smita AS, Achhelal PR. Feasibility and utility of ultrasonography in evaluation of diaphragmatic motion and thickness in Indian population. Int J Health Sci 2017;7(5):60–65.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nivolumab;Reactions Weekly;2023-03-11